Alexander Geissler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexander Geissler has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
- Justus Vogel
Chair of Health Economics, Policy and Management, School of Medicine, University of St. Gallen, St. Gallen, Switzerland
16 shared publications - David Kuklinski
Affiliation Chair of Health Economics, Policy and Management, School of Medicine, University of St. Gallen, St. Gallen Switzerland
10 shared publications - Wilm Quentin
Department for Planetary and Public Health, Universität Bayreuth, Bayreuth, Germany
10 shared publications Reinhard Busse
Department of Health Care Management, Technische Universität (TU) Berlin, Straße des 17. Juni 135, 10623, Berlin, Germany; European Observatory on Health Systems and Policies, Belgium, Brussels
8 shared publications- Anja Yvonne Bischof
Chair of Health Economics, Policy, and Management, School of Medicine, University of St. Gallen
7 shared publications - Reinhard Busse
Department of Health Care Management, Technische Universität Berlin, Berlin, Germany
7 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by Taylor & Francis in Health Literacy and Communication Open
- Vol. 4 (1)
What do COPD patients with low health literacy need to enhance their self-management? - Evidence from Swiss survey data
1. Chronic obstructive pulmonary disease (COPD) is one of the major global health concerns. It affects more than 400 million people globally and remains one of the leading causes of death (World He...
- 18 August 2026
- Published by Taylor & Francis in Health Literacy and Communication Open
- Vol. 4 (1)
Open AccessWhat do COPD patients with low health literacy need to enhance their self-management? - Evidence from Swiss survey data
1. Chronic obstructive pulmonary disease (COPD) is one of the major global health concerns. It affects more than 400 million people globally and remains one of the leading causes of death (World He...
- Open Access
- 8 August 2026
- Published by Springer Nature in Journal of Medical Systems
- Vol. 50 (1) , 124
Does System Choice Matter? Influence of Hospital Information Systems on Digital Maturity
Hospitals worldwide invest heavily in digital infrastructure to improve efficiency, safety, and patient-centeredness. Hospital Information Systems (HIS) form the backbone of these efforts. However, the HIS provider market remains fragmented and heterogeneous, thus potentially influencing hospitals’ ability to achieve digital transformation. Empirical evidence on how HIS choice relates to digital maturity remains limited. Using data from more than 1,600 hospitals participating in the German-wide DigitalRadar (DR) project (i.e., covering about 90% of all hospitals), we examined the relationship between HIS provider characteristics and hospitals’ digital maturity. The DR dataset comprises 234 standardized items per hospital and provides a maturity score from 0 to 100 for each hospital. Four HIS provider features (i.e., module utilization, integration ratio, external provider variation, and maximum hospital size coverage) were derived and used for k -means clustering. Multivariate linear regressions, controlling for hospital characteristics, quantified associations with digital maturity. K -means clustering identified four clusters of HIS providers. Higher module utilization (β = 6.87, p < 0.05) and integration ratios (β = 14.35, p < 0.01) were consistently associated with greater digital maturity. External provider variation and maximum hospital size coverage were not significantly associated with overall digital maturity. The choice of HIS provider is associated with hospitals’ digital maturity, particularly with respect to broader module coverage and stronger integration. Providers with low module utilization and limited integration are associated with lower maturity. Our findings highlight the need for strategic HIS procurement, targeted system/organizational improvements, and policy incentives to accelerate digital transformation.
- 8 August 2026
- Published by Springer Nature in Journal of Medical Systems
- Vol. 50 (1) , 124
Open AccessDoes System Choice Matter? Influence of Hospital Information Systems on Digital Maturity
Hospitals worldwide invest heavily in digital infrastructure to improve efficiency, safety, and patient-centeredness. Hospital Information Systems (HIS) form the backbone of these efforts. However, the HIS provider market remains fragmented and heterogeneous, thus potentially influencing hospitals’ ability to achieve digital transformation. Empirical evidence on how HIS choice relates to digital maturity remains limited. Using data from more than 1,600 hospitals participating in the German-wide DigitalRadar (DR) project (i.e., covering about 90% of all hospitals), we examined the relationship between HIS provider characteristics and hospitals’ digital maturity. The DR dataset comprises 234 standardized items per hospital and provides a maturity score from 0 to 100 for each hospital. Four HIS provider features (i.e., module utilization, integration ratio, external provider variation, and maximum hospital size coverage) were derived and used for k -means clustering. Multivariate linear regressions, controlling for hospital characteristics, quantified associations with digital maturity. K -means clustering identified four clusters of HIS providers. Higher module utilization (β = 6.87, p < 0.05) and integration ratios (β = 14.35, p < 0.01) were consistently associated with greater digital maturity. External provider variation and maximum hospital size coverage were not significantly associated with overall digital maturity. The choice of HIS provider is associated with hospitals’ digital maturity, particularly with respect to broader module coverage and stronger integration. Providers with low module utilization and limited integration are associated with lower maturity. Our findings highlight the need for strategic HIS procurement, targeted system/organizational improvements, and policy incentives to accelerate digital transformation.
- Open Access
- 3 June 2026
- Published by BMJ in BMJ Quality & Safety
- Vol. 35 (8) , 565-575
Welcome to the jungle: collection and evaluation of quality indicators with the QUALICATOR instrument
The rapid growth in quality indicators (QIs) has increased complexity in selecting those that are effective for monitoring provider quality and patient outcomes. Existing selection methodologies are often insufficiently transparent or standardised and influenced by subjective opinions. To develop an instrument for evidence-based collection and evaluation of QIs that are suitable for quality monitoring, and which can be applied to various healthcare areas (HCAs; defined by care setting). The instrument was developed with HCA-specific experts, who provided feedback on its components and piloted its use in the Swiss context. We conducted a literature search with snowballing to identify prioritisation criteria and weighted these using the Analytic Hierarchy Process (AHP). We developed a template to facilitate data collection and the QI evaluation. The final QUALICATOR instrument consists of five steps: (1) definition of search scope; (2) utilisation of 12 prioritisation criteria across four dimensions (relevance, scientific soundness, usability, feasibility); (3) application of a data collection template objectifying the prioritisation criteria; (4) preselection via knockout criteria and (5) final prioritisation via weighting multicriteria decision analysis. Final criteria weights derived via the AHP varied substantially across HCAs (eg, relevance: 19.16%–57.10%; scientific soundness: 5.50%–39.50%; usability: 13.17%–33.75%; feasibility: 11.78%–45.57%), reflecting HCA-specific priorities. A web-based prototype is available to support a user-friendly application. This QUALICATOR instrument provides a transparent, scalable approach to navigate through a growing body of QIs with further validation needed. It provides a methodological framework and proof of concept, rather than a ready-to-use solution. It shows policymakers, providers and payers a path to make informed decisions about which QIs to prioritise, monitor, invest in and act on.
- 3 June 2026
- Published by BMJ in BMJ Quality & Safety
- Vol. 35 (8) , 565-575
Open AccessWelcome to the jungle: collection and evaluation of quality indicators with the QUALICATOR instrument
The rapid growth in quality indicators (QIs) has increased complexity in selecting those that are effective for monitoring provider quality and patient outcomes. Existing selection methodologies are often insufficiently transparent or standardised and influenced by subjective opinions. To develop an instrument for evidence-based collection and evaluation of QIs that are suitable for quality monitoring, and which can be applied to various healthcare areas (HCAs; defined by care setting). The instrument was developed with HCA-specific experts, who provided feedback on its components and piloted its use in the Swiss context. We conducted a literature search with snowballing to identify prioritisation criteria and weighted these using the Analytic Hierarchy Process (AHP). We developed a template to facilitate data collection and the QI evaluation. The final QUALICATOR instrument consists of five steps: (1) definition of search scope; (2) utilisation of 12 prioritisation criteria across four dimensions (relevance, scientific soundness, usability, feasibility); (3) application of a data collection template objectifying the prioritisation criteria; (4) preselection via knockout criteria and (5) final prioritisation via weighting multicriteria decision analysis. Final criteria weights derived via the AHP varied substantially across HCAs (eg, relevance: 19.16%–57.10%; scientific soundness: 5.50%–39.50%; usability: 13.17%–33.75%; feasibility: 11.78%–45.57%), reflecting HCA-specific priorities. A web-based prototype is available to support a user-friendly application. This QUALICATOR instrument provides a transparent, scalable approach to navigate through a growing body of QIs with further validation needed. It provides a methodological framework and proof of concept, rather than a ready-to-use solution. It shows policymakers, providers and payers a path to make informed decisions about which QIs to prioritise, monitor, invest in and act on.
- Open Access
- 5 May 2026
- Published by Springer Nature
- p. 37-49
Impulse zur Weiterentwicklung der Leistungsgruppen: Ein Vergleich der Schweiz mit Deutschland
- 5 May 2026
- Published by Springer Nature
- p. 37-49
Open AccessImpulse zur Weiterentwicklung der Leistungsgruppen: Ein Vergleich der Schweiz mit Deutschland
- Open Access
- 5 May 2026
- Published by Springer Nature
- p. 139-155
Flexibilisierung von Qualitätsvorgaben im Rahmen der Krankenhausplanung: Erfahrungen aus der Schweiz am Beispiel der Mindestfallzahlen
- 5 May 2026
- Published by Springer Nature
- p. 139-155
Open AccessFlexibilisierung von Qualitätsvorgaben im Rahmen der Krankenhausplanung: Erfahrungen aus der Schweiz am Beispiel der Mindestfallzahlen
- Open Access
- 7 March 2026
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (6) , 926-937
Utilization rates of knee arthroplasty in OECD countries revised
- 7 March 2026
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (6) , 926-937
Open AccessUtilization rates of knee arthroplasty in OECD countries revised
- Open Access
- 27 February 2026
- Published by Elsevier in SSRN Electronic Journal
What drives regional heterogeneity in hospital reform implementation? Insights from more than one decade of Swiss hospital capacity planning
BackgroundImplementing national hospital reforms is challenging in decentralized health systems, where subnational governments are responsible for execution. However, cross-country learning on regional heterogeneity in reform implementation is limited. In 2012, Switzerland introduced a national hospital reform, with implementation delegated to cantons. We therefore examine Switzerland as a case study. As part of the reform, cantons were required to define service groups for hospital capacity planning, which then followed an assessment of need for care and quality requirements per service group.ObjectivesWe examine whether cantons deviated from the Zurich baseline model, aiming to derive recommendations for the effective implementation of nationwide reforms in decentralized health systems.MethodsWe employed a mixed-methods design. A document analysis and 25 semi-structured interviews with experts and cantonal representatives were combined with an unsupervised cluster analysis, investigating the associations between cantonal characteristics and degree of deviation from the baseline model.ResultsBy 2024, 25 cantons had adopted service groups with varying introduction timepoints and substantial convergence toward the baseline model. Differences in the number of service groups and most requirements were minor. In contrast, minimum volume requirements varied considerably, driven by political feasibility concerns and the perceived risk of financially destabilizing local hospitals.ConclusionThe Swiss case shows that alignment in hospital reform implementation can emerge in decentralized health systems, but is shaped by local contexts, and administrative capacity. Decentralized systems may thus benefit from mandatory national standards combined with transparent mechanisms for local adaptation, enabling a balance between quality, cost, and access considerations.
- 27 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessWhat drives regional heterogeneity in hospital reform implementation? Insights from more than one decade of Swiss hospital capacity planning
BackgroundImplementing national hospital reforms is challenging in decentralized health systems, where subnational governments are responsible for execution. However, cross-country learning on regional heterogeneity in reform implementation is limited. In 2012, Switzerland introduced a national hospital reform, with implementation delegated to cantons. We therefore examine Switzerland as a case study. As part of the reform, cantons were required to define service groups for hospital capacity planning, which then followed an assessment of need for care and quality requirements per service group.ObjectivesWe examine whether cantons deviated from the Zurich baseline model, aiming to derive recommendations for the effective implementation of nationwide reforms in decentralized health systems.MethodsWe employed a mixed-methods design. A document analysis and 25 semi-structured interviews with experts and cantonal representatives were combined with an unsupervised cluster analysis, investigating the associations between cantonal characteristics and degree of deviation from the baseline model.ResultsBy 2024, 25 cantons had adopted service groups with varying introduction timepoints and substantial convergence toward the baseline model. Differences in the number of service groups and most requirements were minor. In contrast, minimum volume requirements varied considerably, driven by political feasibility concerns and the perceived risk of financially destabilizing local hospitals.ConclusionThe Swiss case shows that alignment in hospital reform implementation can emerge in decentralized health systems, but is shaped by local contexts, and administrative capacity. Decentralized systems may thus benefit from mandatory national standards combined with transparent mechanisms for local adaptation, enabling a balance between quality, cost, and access considerations.
- Open Access
- 23 December 2025
- Published by Springer Nature in Trials
- Vol. 26 (1) , 577
Enhancing type 2 diabetes care by an individualized and group-based therapeutic patient education program: study protocol for a cluster randomized trial
Background: Type 2 diabetes (T2D) presents a significant challenge to health systems and its prevalence is projected to increase. T2D is significantly influenced by lifestyle factors, including diet and physical activity. This makes therapeutic patient education (TPE) a pivotal component of T2D treatment strategies. While in some countries, like Germany and the UK, TPE elements like physician counselling regarding lifestyle changes (e.g., nutrition, smoking, exercise) and participation in diabetes education courses are part of structured nationwide disease management programs; in Switzerland, TPE elements are rarely part of the standard of care protocols. Our goal is to evaluate whether an interdisciplinary and individualized T2D program including TPE elements improves patients’ health outcomes. Methods: The study is a multi-center cluster randomized controlled trial in the canton of Geneva in Western Switzerland. We aim to include a minimum of 154 recently diagnosed T2D patients from around 30 primary care physician (PCP) practices. Practices are randomized with a 1:1 patient allocation ratio to either intervention or control group using covariate constrained randomization. The intervention lasts 12 months with a 6-month follow-up and consists of two steps. First, PCPs in the intervention group and associated healthcare professionals (e.g., dieticians, physical therapists) are trained in interprofessional group sessions on TPE elements by specialists. Second, patients follow an individualized treatment plan which is designed within an initial quality circle with their PCP, other healthcare professionals, a TPE specialist, a dedicated study manager, and other patients. The treatment plan is accompanied by regular patient-reported outcome measure (PROM) collections, which are discussed in patients’ regular PCP visits. Patients in the control group follow standard of care. Primary endpoint is the 12 months mean change in HbA1c levels, secondary endpoints are the 18 months mean change in HbA1c levels, the 12 and 18 months mean changes in patient-reported outcomes (EQ-5D-5L, DIAB-Q), mean changes in medical outcomes (blood pressure, body composition, medication intake), and patient experience. We further evaluate cost-effectiveness from the payer perspective. Discussion: A positive evaluation of the study can inform a wider roll-out of the T2D program within Switzerland and be a cornerstone for better patient health outcomes for T2D patients. Trial registration: ClinicalTrials.gov: NCT06774950. Registered on 14 January 2025
- 23 December 2025
- Published by Springer Nature in Trials
- Vol. 26 (1) , 577
Open AccessEnhancing type 2 diabetes care by an individualized and group-based therapeutic patient education program: study protocol for a cluster randomized trial
Background: Type 2 diabetes (T2D) presents a significant challenge to health systems and its prevalence is projected to increase. T2D is significantly influenced by lifestyle factors, including diet and physical activity. This makes therapeutic patient education (TPE) a pivotal component of T2D treatment strategies. While in some countries, like Germany and the UK, TPE elements like physician counselling regarding lifestyle changes (e.g., nutrition, smoking, exercise) and participation in diabetes education courses are part of structured nationwide disease management programs; in Switzerland, TPE elements are rarely part of the standard of care protocols. Our goal is to evaluate whether an interdisciplinary and individualized T2D program including TPE elements improves patients’ health outcomes. Methods: The study is a multi-center cluster randomized controlled trial in the canton of Geneva in Western Switzerland. We aim to include a minimum of 154 recently diagnosed T2D patients from around 30 primary care physician (PCP) practices. Practices are randomized with a 1:1 patient allocation ratio to either intervention or control group using covariate constrained randomization. The intervention lasts 12 months with a 6-month follow-up and consists of two steps. First, PCPs in the intervention group and associated healthcare professionals (e.g., dieticians, physical therapists) are trained in interprofessional group sessions on TPE elements by specialists. Second, patients follow an individualized treatment plan which is designed within an initial quality circle with their PCP, other healthcare professionals, a TPE specialist, a dedicated study manager, and other patients. The treatment plan is accompanied by regular patient-reported outcome measure (PROM) collections, which are discussed in patients’ regular PCP visits. Patients in the control group follow standard of care. Primary endpoint is the 12 months mean change in HbA1c levels, secondary endpoints are the 18 months mean change in HbA1c levels, the 12 and 18 months mean changes in patient-reported outcomes (EQ-5D-5L, DIAB-Q), mean changes in medical outcomes (blood pressure, body composition, medication intake), and patient experience. We further evaluate cost-effectiveness from the payer perspective. Discussion: A positive evaluation of the study can inform a wider roll-out of the T2D program within Switzerland and be a cornerstone for better patient health outcomes for T2D patients. Trial registration: ClinicalTrials.gov: NCT06774950. Registered on 14 January 2025
- 12 November 2025
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Effects of Hospital Planning on Quality, Costs, Efficiency, and Access in OECD Countries: A Protocol for a Systematic Review
INPLASY2025110032 Effects of Hospital Planning on Quality, Costs, Efficiency, and Access in OECD Countries: A Protocol for a Systematic Review Keywords: Hospital Planning, Hospital Capacity Plannin…
- 12 November 2025
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Effects of Hospital Planning on Quality, Costs, Efficiency, and Access in OECD Countries: A Protocol for a Systematic Review
INPLASY2025110032 Effects of Hospital Planning on Quality, Costs, Efficiency, and Access in OECD Countries: A Protocol for a Systematic Review Keywords: Hospital Planning, Hospital Capacity Plannin…
- Open Access
- 23 September 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 33 (12) , 1475-1484
Utilization rates of hip arthroplasty in OECD countries revised
- 23 September 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 33 (12) , 1475-1484
Open AccessUtilization rates of hip arthroplasty in OECD countries revised